BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2352332)

  • 1. Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus env proteins possess a functionally conserved assembly domain.
    Doms RW; Earl PL; Chakrabarti S; Moss B
    J Virol; 1990 Jul; 64(7):3537-40. PubMed ID: 2352332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The V1 region of gp120 is preferentially selected during SIV/HIV transmission and is indispensable for envelope function and virus infection.
    Li Y; Dittmer U; Wang Y; Song J; Sun B; Yang R
    Virol Sin; 2016 Jun; 31(3):207-18. PubMed ID: 27117672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of the gp120 V3 loop to envelope glycoprotein trimer stability in primate immunodeficiency viruses.
    Bowder D; Hollingsead H; Durst K; Hu D; Wei W; Wiggins J; Medjahed H; Finzi A; Sodroski J; Xiang SH
    Virology; 2018 Aug; 521():158-168. PubMed ID: 29936340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus.
    Chertova E; Bess JW; Crise BJ; Sowder II RC; Schaden TM; Hilburn JM; Hoxie JA; Benveniste RE; Lifson JD; Henderson LE; Arthur LO
    J Virol; 2002 Jun; 76(11):5315-25. PubMed ID: 11991960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
    Welman M; Lemay G; Cohen EA
    Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmission.
    Gonzalez MW; DeVico AL; Lewis GK; Spouge JL
    J Virol; 2015 Apr; 89(7):3619-29. PubMed ID: 25589663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding.
    Sattentau QJ; Moore JP; Vignaux F; Traincard F; Poignard P
    J Virol; 1993 Dec; 67(12):7383-93. PubMed ID: 7693970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail.
    Wyss S; Dimitrov AS; Baribaud F; Edwards TG; Blumenthal R; Hoxie JA
    J Virol; 2005 Oct; 79(19):12231-41. PubMed ID: 16160149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoting trimerization of soluble human immunodeficiency virus type 1 (HIV-1) Env through the use of HIV-1/simian immunodeficiency virus chimeras.
    Center RJ; Lebowitz J; Leapman RD; Moss B
    J Virol; 2004 Mar; 78(5):2265-76. PubMed ID: 14963123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lineage-Specific Differences between the gp120 Inner Domain Layer 3 of Human Immunodeficiency Virus and That of Simian Immunodeficiency Virus.
    Ding S; Medjahed H; Prévost J; Coutu M; Xiang SH; Finzi A
    J Virol; 2016 Nov; 90(22):10065-10073. PubMed ID: 27535053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfation of the human immunodeficiency virus envelope glycoprotein.
    Bernstein HB; Compans RW
    J Virol; 1992 Dec; 66(12):6953-9. PubMed ID: 1433500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HIV-1, HIV-2 and SIV envelope glycoprotein-mediated cell fusion by calmodulin.
    Malvoisin E; Wild F
    Virus Res; 1997 Aug; 50(2):119-27. PubMed ID: 9282777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic peptides and anti-peptide antibodies as probes to study interdomain interactions involved in virus assembly: the envelope of the human immunodeficiency virus (HIV-1).
    Neurath AR; Strick N; Jiang S
    Virology; 1992 May; 188(1):1-13. PubMed ID: 1373549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the cytoplasmic domain of the simian immunodeficiency virus envelope protein on incorporation of heterologous envelope proteins and sensitivity to neutralization.
    Vzorov AN; Compans RW
    J Virol; 2000 Sep; 74(18):8219-25. PubMed ID: 10954518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Envelope glycoprotein determinants of increased entry in a pathogenic simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) passaged in monkeys.
    Si Z; Gorry P; Babcock G; Owens CM; Cayabyab M; Phan N; Sodroski J
    AIDS Res Hum Retroviruses; 2004 Feb; 20(2):163-73. PubMed ID: 15018704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain.
    Fenouillet E; Jones I; Powell B; Schmitt D; Kieny MP; Gluckman JC
    J Virol; 1993 Jan; 67(1):150-60. PubMed ID: 8093218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.
    Postler TS; Desrosiers RC
    J Virol; 2013 Jan; 87(1):2-15. PubMed ID: 23077317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: conserved helical interactions underlie the broad inhibitory activity of gp41 peptides.
    Malashkevich VN; Chan DC; Chutkowski CT; Kim PS
    Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9134-9. PubMed ID: 9689046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein.
    Earl PL; Doms RW; Moss B
    Proc Natl Acad Sci U S A; 1990 Jan; 87(2):648-52. PubMed ID: 2300552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable constraints on the principal immunodominant domain of the transmembrane glycoprotein of human immunodeficiency virus type 1.
    Merat R; Raoul H; Leste-Lasserre T; Sonigo P; Pancino G
    J Virol; 1999 Jul; 73(7):5698-706. PubMed ID: 10364320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.